Patents
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
09/2004
09/22/2004EP1458382A1 Amide derivatives as gk activators
09/22/2004EP1458375A2 Compositions for decreasing activity of hormone-sensitive lipase
09/22/2004EP1458374A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
09/22/2004EP1153014B1 Beta-alanine derivatives
09/22/2004EP1140860B1 Pyrimidine compounds
09/22/2004EP1100503B1 Non-imidazole alkylamines as histamine h 3?-receptor ligands and their therapeutic applications
09/22/2004EP1077950B1 Novel diphenyl-substituted 6-ring-heterocycles, methods for producing them and their use as medicaments
09/22/2004EP0623133B1 Substituted amino alkyl compounds
09/22/2004CN1531444A Synthetic catalyst for selective cleavage of protein and method for selective cleavage of protein using same
09/22/2004CN1167422C Quinazoline derivatives as angiogenesis inhibitors
09/21/2004US6794506 Treatment of inflammatory diseases, such as asthma, alzheimer's disease, atherosclerosis, aids dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, tissue transplantation, tumor metastasis
09/21/2004US6794397 Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof
09/21/2004US6794379 Antiinflammatory agents; autoimmune disease; skin disorders
09/21/2004US6794378 Heterocyclic compounds and medical use thereof
09/21/2004US6794377 Ortho, ortho-substituted nitrogen-containing bisaryl compounds, useful for the treatment and prophylaxis of atrial arrhymias, e.g. atrail fibrillation or atrial flutters
09/21/2004US6794372 Nitrate salts of antimicrobial agents
09/21/2004CA2076226C Substituted 1-pyrimidinylacetamide compounds
09/16/2004WO2004078733A1 Quinazolines useful as modulators of ion channels
09/16/2004WO2004078725A1 Process for the preparation of pyridinyl and pyrimidinyl mono-fluorinated beta keto esters
09/16/2004WO2004078109A2 PROCESS FOR SYNTHESISING USEFUL INTERMEDIATES FOR THE PREPARATION OF ανβ3 RECEPTOR ANTAGONISTS
09/16/2004WO2004064972A9 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
09/16/2004WO2004047739A3 Pyridinyl, pyrimidinyl and pyrazinyl amides as potassium channel openers
09/16/2004WO2004046101A3 Cyanoguanidines and cyanoamidines as erbb2 and egfr inhibitors
09/16/2004WO2003094839A3 Pyrimidinone compounds, compositions and methods
09/16/2004WO2003028729A3 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade
09/16/2004US20040181073 Amides, useful in the inhibition of il-8-induced chemotaxis of neutrophils
09/16/2004US20040181065 Process for preparing 2-amino-4-(4-fluorphenyl) -6-alkylpyrimidine-5-carboxylate
09/16/2004US20040180964 anti-obestic activity; Neuropeptide Y antagonist
09/16/2004US20040180947 Sulfonamide compounds and pharmaceutical use thereof
09/16/2004US20040180914 5-Cyano-2-aminopyrimidine derivatives
09/16/2004US20040180913 Antimalarial pyrimidine derivatives and methods of making and using them
09/16/2004US20040180912 for promoting the release of parathyroid hormone, e.g. for preventing or treating bone conditions which are associated with increased calcium depletion or resorption or in which stimulation of bone formation and calcium fixation in the bone is desirable
09/16/2004US20040180906 Anti-inflammatory medicaments
09/16/2004US20040180901 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents
09/16/2004US20040180892 control of cardiovascular homeostasis is achieved through a combination of both direct neuronal control and systemic neurohormonal activation
09/16/2004US20040180095 Biodegradable microspheres are administered by stereotactic injection directly into the tumor, into the peritumoral area or at the same time into the tumor and the peritumoral area
09/16/2004CA2517844A1 Quinazolines useful as modulators of ion channels
09/15/2004EP1457489A1 Process for the preparation of 4-alkyl pyrimidines
09/15/2004EP1457199A1 Coupling agents having a 2,3,5-triaminopyridine structure and their use for dyeing keratinic fibres
09/15/2004EP1456183A2 Process for preparing 1-(carboxymethyl)-and 1-(aminocarbonyl)-pyrimidin-4-one derivates
09/15/2004EP1456182A1 Pyrimidine derivatives as modulators of insuline-like growth factor-1 receptor (igf-i)
09/15/2004EP1456171A1 Substituted cyclohexane derivatives
09/15/2004EP1455790A1 Use of pyridine-2,4-dicarboxylic acid diamides and of pyrimidine-4,6-dicarboxylic acid diamides for selective collagenase inhibition
09/15/2004EP1140515B1 Heat sensitive recording material
09/15/2004EP0986384A4 Inhibitors of protein isoprenyl transferases
09/15/2004CN1528751A Process for preparing 4,6-dichloropyrimidine
09/15/2004CN1528750A Pyrimidine derivatives and preparing method thereof
09/15/2004CN1166645C Bicyclic heterocyles, medicaments contg. these compounds, their use and methods for prodn. thereof
09/15/2004CN1166644C Process for chemically synthesizing 2,6-bis [(4,6-dimethoxypyrimidine-2-yl) oxy] sodium bezoate
09/15/2004CN1166643C 4-phenyl-pyrimidine derivatives
09/15/2004CN1166292C Method of pereparing underwater foamed type solid composition of agricultural chemical product
09/14/2004US6790955 Reacting 2-sulfonamido, nitrobenzoic acid compound with in the presence of a halogenating agent, with formation of the carbonyl halide and its rearrangement; ammonolysis at so2cl group reducing at the nitro group; reacting with carbamate
09/14/2004US6790885 Chlorine containing polymer compositions containing stabilizers which impart good thermal stability. pvc compositions and, in particular, flexible pvc compositions containing stabilizers which are oligomeric and/or polymeric
09/14/2004US6790850 Thiazolo(4,5-d)pyrimidine compounds
09/14/2004US6790841 2-hydroxymethylcyclopropylidenemethylpurines and -pyrimidines as antiviral agents
09/10/2004WO2004076420A1 Heteroarylcarbamoylbenzene derivative
09/10/2004WO2004075864A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
09/10/2004WO2003084982A3 Functionalized compositions for improved immobilization
09/10/2004WO2003079984A3 Substituted tetracycline compounds
09/10/2004CA2516407A1 Heteroarylcarbamoylbenzene derivatives
09/09/2004US20040176615 Forming calcium salt from ester
09/09/2004US20040176595 Glucocorticoid receptor modulators
09/09/2004US20040176594 Drugs that inhibit phosphorylation kinases as an antigrowth or antiproliferation agent
09/09/2004US20040176462 NPY Y5 antagonist
09/09/2004US20040176461 Sulfonyl-amino or carbonyl-amino derivatives; osteoporosis bone disorders; therapeutic drug or kits including anti-resorptive agents, anabolic agents;
09/09/2004US20040176458 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
09/09/2004US20040176401 preparing a 2-(N-methyl-N-methanesulfonylamino)pyrimidine by reacting a hydroxypyrimidine with an organic sulfonyl halide; without employing a toxic compound
09/09/2004US20040176400 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf)
09/09/2004US20040176399 A2B adenosine receptor antagonists
09/09/2004US20040176386 Compounds
09/09/2004US20040176385 treating cancer by inhibiting phosphotidylinositol 3-kinase; in combination with other known agents to modulate cellular proliferation
09/09/2004US20040176361 2H-Isoquinolin-1-one derivatives as poly/ADP-ribose/ polymerase inhibitors
09/09/2004US20040176271 2-amino-4-aryl or heteroaryl pyridines or pyrimidines; Janus kinases (JAK)
09/09/2004US20040173777 Fluorescent diketopyrrolopyrrole analogues
09/09/2004DE10306445A1 Production of 4-alkylpyrimidines comprises adding a formylmethyl alkyl ketone diacetal to formamide at a temperature such that the product can be removed from the reaction mixture by distillation
09/08/2004EP1454907A1 Quninazoline and pyridopyrmidine derivatives
09/08/2004EP1454900A1 Process for the preparation of pyridinyl and pyrimidinyl mono-fluorinated beta keto-esters
09/08/2004EP1454898A1 Novel phenylalanine derivative
09/08/2004EP1453823A1 2-guanidino-4-heterocyclylquinazolines
09/08/2004EP1453789A2 N,n'-substituted-1,3-diamino-2-hydroxypropane derivatives
09/08/2004EP1453516A2 Novel tri-substituted pyrimidines, method for production and use thereof as medicament
09/08/2004EP1345603A4 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
09/08/2004EP1268408B1 Arthropodicidal carboxanilides
09/08/2004EP1194416B1 Halopyrimidines
09/08/2004EP1165505B1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
09/08/2004EP0824524B1 Alpha-substituted pyrimidine-thioalkyl and alkylether compounds as inhibitors of viral reverse transcriptase
09/08/2004CN1527821A Preparation of aminopyrimidine compounds
09/08/2004CN1527709A Therapeutic combinations for cardiovascular and inflammatory indications
09/08/2004CN1165527C Substituted aryl sulphonyl (thio) ureas used as herbicides
09/07/2004US6787544 Useful for prophylaxis and therapy of virus infections and especially influenza virus infections
09/07/2004US6787542 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
09/07/2004US6787539 2,4,5,-trisubstituted pyrimidine derivatives
09/07/2004US6787536 Hydroxamic acid derivatives
09/07/2004CA2105709C Substituted cyclohexane derivatives, processes for their preparation and the use of the compounds for treating diseases
09/02/2004WO2004074274A1 Substituted n-aryl nitrogen heterocycles
09/02/2004WO2004074264A1 Process for producing phenylalanine derivative having quinazolinedione skeleton and intermediate for the same
09/02/2004WO2004074262A1 Hiv replication inhibiting pyrimidines and triazines
09/02/2004WO2004074261A1 Hiv replication inhibiting pyrimidines and triazines
09/02/2004WO2004074259A1 Aryl acid pyrimidinyl methyl amides, pyridazinyl methyl amides and related compounds
09/02/2004WO2004074244A2 Pyrimidine compounds